|
Volumn 3, Issue 3, 2014, Pages 526-536
|
HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up study
a a a a a a a |
Author keywords
GATA4; granulosa cell tumor; HER2; prognostic factor; recurrence; survival
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
GATA4 PROTEIN, HUMAN;
TRANSCRIPTION FACTOR GATA 4;
ADULT;
AGED;
BIOSYNTHESIS;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
GENE EXPRESSION REGULATION;
GENETICS;
GRANULOSA CELL TUMOR;
HUMAN;
MIDDLE AGED;
PATHOLOGY;
PROGNOSIS;
TUMOR RECURRENCE;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
GATA4 TRANSCRIPTION FACTOR;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GRANULOSA CELL TUMOR;
HUMANS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
RECEPTOR, ERBB-2;
|
EID: 84897907775
PISSN: None
EISSN: 20457634
Source Type: Journal
DOI: 10.1002/cam4.230 Document Type: Article |
Times cited : (30)
|
References (0)
|